Page 13 - Pfizer

Pfizer, Moderna vaccines effective against Covid variants from India: Study

The Pfizer/BioNTech and Moderna coronavirus vaccines appear to protect against Covid variants B.1.617 and B.1.618 first identified in India, researchers have reported in a new pre-print paper

Should my child get coronavirus vaccine? 7 questions answered by an expert

US FDA has expanded emergency use authorization of the Pfizer-BioNTech Covid-19 vaccine to include adolescents 12 to 15 years of age

Second Pfizer shot after 12 weeks produces more antibodies: Study

Extending 2nd dose interval increases the peak antibody response 3.5-fold

US CDC panel recommends Pfizer Covid-19 vaccine for 12-15 age group

An advisory panel of the Centres for Disease Control and Prevention on Wednesday (local time) recommended the use of Pfizer-BioNTech Covid-19 vaccine for children aged between 12 and 15

Pfizer Covid-19 vaccine now expanded to US children as young as 12

The study found no cases of Covid-19 among fully vaccinated adolescents compared to 18 among kids given dummy shots

FDA allows emergency use of Pfizer-BioNTech vax in adolescents aged 12-15

The US Food and Drug Administration (FDA)authorised the emergency use of Pfizer-BioNTech Covid-19 vaccine in adolescents aged 12-15 for the prevention of Covid-19

Sri Lanka approves Pfizer coronavirus vaccine for emergency use

Sri Lanka is the first country in South Asia to approve the Pfizer vaccine

Pfizer aims for full FDA approval of Covid vaccine for people 16 and above

Pfizer Chief Executive Albert Bourla said in a statement that the companies are aiming to win full regulatory approval in the coming months

Pfizer-BioNTech vaccine is highly effective against variants, studies find

Previous research suggested that B.1.1.7 is more infectious and more deadly than other variants, but that vaccines still worked well against it

Pfizer Covid-19 vaccine linked with fewer asymptomatic infections: Study

People who received the Pfizer Covid-19 vaccine at a US hospital had dramatically lower symptomatic and asymptomatic infections compared with their unvaccinated peers, according to a study

Pfizer-BioNTech start full US approval application for Covid-19 vaccine

If approved, the vaccine will be the first fully approved Covid-19 shot and could help ease vaccine hesitancy due to longer-term data required for an FDA approval

Covid jabs for kids in 2-11 age group: Pfizer to seek approval in Sep

Pfizer will likely seek the US Food and Drug Administration's emergency authorisation to administer its coronavirus vaccine among children between the ages of 2 and 11 in September, media reports

Pfizer lifts sales forecast for coronavirus vaccine to $26 billion

This is reflecting new contracts with governments around the world trying to halt the pandemic through rapid vaccination.

Discussions on with India for 'expedited approval' of Covid vaccine: Pfizer

'We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country,' says Pfizer CEO in a LinkedIn post

Pfizer donates USD 70 mn worth Covid-19 treatment drugs to India

Global pharma major Pfizer is sending its medicines worth USD 70 million from its distribution centres in the US, Europe and Asia

Single dose of Pfizer vaccine cuts Covid-19 spread by half: Study

Protection against coronavirus seen from about 14 days after vaccination

Unanswered questions

Govt should remove uncertainty about next phase of vaccination

Hope Biden asks Pfizer to allow India develop its vaccines: US Congressman

With millions of lives at stake amid a rapid spread of Covid-19, Indian-American Congressman Ro Khanna said he hoped President Joe Biden would call the Pfizer CEO to let India produce its vaccine

Covid vaccine: Sputnik safest, Pfizer's shot worst? Row over Hungary data

The Russian vaccine has six times lower infection rate than Pfizer's

Centre won't import vaccines, wants states and companies to do so: Report

Two govt officials said New Delhi is now leaving it up to states, companies to sign deals with foreign drugmakers while it buys in bulk most of the output of local producers - SII and Bharat Biotech